Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00316953
Status:
COMPLETED
Last Update Posted:
2013-02-05
First Post:
2006-04-19
Brief Title:
Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unspecified Childhood Solid Tumor Protocol Specific |
| Accelerated Phase Chronic Myelogenous Leukemia |
| Blastic Phase Chronic Myelogenous Leukemia |
| Childhood Chronic Myelogenous Leukemia |
| Chronic Myelogenous Leukemia BCR-ABL1 Positive |
| Meningeal Chronic Myelogenous Leukemia |
| Recurrent Childhood Acute Lymphoblastic Leukemia |
| Relapsing Chronic Myelogenous Leukemia |
Keywords: